• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy
    Subscribe to $OABI

    OmniAb Inc.

    Subscribe to $OABI
    $OABI
    Biotechnology: Commercial Physical & Biological Resarch
    Health Care

    IPO Year: 2021

    Exchange: NASDAQ

    Recent Analyst Ratings for OmniAb Inc.

    DatePrice TargetRatingAnalyst
    11/29/2023$6.00Outperform
    RBC Capital Mkts
    4/21/2023$8.00Buy
    The Benchmark Company
    4/13/2023$10.00Buy
    Craig Hallum
    2/22/2023$10.00Outperform
    Cowen
    2/13/2023$11.00Buy
    H.C. Wainwright
    See more ratings

    OmniAb Inc. Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Cochran Jennifer R. bought $45,600 worth of shares (30,000 units at $1.52), increasing direct ownership by 26% to 145,274 units (SEC Form 4)

      4 - OmniAb, Inc. (0001846253) (Issuer)

      5/15/25 4:02:17 PM ET
      $OABI
      Biotechnology: Commercial Physical & Biological Resarch
      Health Care
    • Director Love Steven bought $36,500 worth of shares (25,000 units at $1.46), increasing direct ownership by 188% to 38,333 units (SEC Form 4)

      4 - OmniAb, Inc. (0001846253) (Issuer)

      5/14/25 5:04:09 PM ET
      $OABI
      Biotechnology: Commercial Physical & Biological Resarch
      Health Care
    • Director Higgins John L bought $93,600 worth of shares (65,000 units at $1.44), increasing direct ownership by 2% to 2,831,887 units (SEC Form 4)

      4 - OmniAb, Inc. (0001846253) (Issuer)

      5/13/25 5:52:02 PM ET
      $OABI
      Biotechnology: Commercial Physical & Biological Resarch
      Health Care
    • Director Higgins John L bought $9,120 worth of shares (4,000 units at $2.28), increasing direct ownership by 0.14% to 2,766,887 units (SEC Form 4)

      4 - OmniAb, Inc. (0001846253) (Issuer)

      3/21/25 7:58:52 PM ET
      $OABI
      Biotechnology: Commercial Physical & Biological Resarch
      Health Care
    • Director Higgins John L bought $295,512 worth of shares (125,750 units at $2.35), increasing direct ownership by 5% to 2,762,887 units (SEC Form 4)

      4 - OmniAb, Inc. (0001846253) (Issuer)

      3/20/25 8:15:52 PM ET
      $OABI
      Biotechnology: Commercial Physical & Biological Resarch
      Health Care
    • Foehr Matthew W bought $1,059,840 worth of shares (240,000 units at $4.42), increasing direct ownership by 7% to 3,536,665 units (SEC Form 4)

      4 - OmniAb, Inc. (0001846253) (Issuer)

      5/28/24 5:55:57 PM ET
      $OABI
      Biotechnology: Commercial Physical & Biological Resarch
      Health Care
    • Foehr Matthew W bought $1,167,750 worth of shares (225,000 units at $5.19), increasing direct ownership by 8% to 2,908,803 units (SEC Form 4)

      4 - OmniAb, Inc. (0001846253) (Issuer)

      3/25/24 7:07:54 AM ET
      $OABI
      Biotechnology: Commercial Physical & Biological Resarch
      Health Care